JP2020529208A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020529208A5 JP2020529208A5 JP2020505253A JP2020505253A JP2020529208A5 JP 2020529208 A5 JP2020529208 A5 JP 2020529208A5 JP 2020505253 A JP2020505253 A JP 2020505253A JP 2020505253 A JP2020505253 A JP 2020505253A JP 2020529208 A5 JP2020529208 A5 JP 2020529208A5
- Authority
- JP
- Japan
- Prior art keywords
- mrna
- utr
- skin
- fgf
- systems
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023115343A JP2023145532A (ja) | 2017-07-31 | 2023-07-13 | 局所皮膚低栄養状態の治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17183990.5A EP3437650A1 (en) | 2017-07-31 | 2017-07-31 | Treatment of local skin hypotrophy conditions |
| EP17183990.5 | 2017-07-31 | ||
| PCT/EP2018/070712 WO2019025431A1 (en) | 2017-07-31 | 2018-07-31 | TREATMENT OF LOCAL SKIN HYPOTROPHIC CONDITIONS |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023115343A Division JP2023145532A (ja) | 2017-07-31 | 2023-07-13 | 局所皮膚低栄養状態の治療 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020529208A JP2020529208A (ja) | 2020-10-08 |
| JP2020529208A5 true JP2020529208A5 (cg-RX-API-DMAC7.html) | 2021-09-09 |
Family
ID=59506101
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020505253A Pending JP2020529208A (ja) | 2017-07-31 | 2018-07-31 | 局所皮膚低栄養状態の治療 |
| JP2023115343A Withdrawn JP2023145532A (ja) | 2017-07-31 | 2023-07-13 | 局所皮膚低栄養状態の治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023115343A Withdrawn JP2023145532A (ja) | 2017-07-31 | 2023-07-13 | 局所皮膚低栄養状態の治療 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20200369738A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3437650A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2020529208A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20200035073A (cg-RX-API-DMAC7.html) |
| CN (1) | CN111050785A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2018311128A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3070880A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2019025431A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12115230B2 (en) * | 2020-04-09 | 2024-10-15 | Verve Therapeutics, Inc. | Base editing of ANGPTL3 and methods of using same for treatment of disease |
| US20220015986A1 (en) * | 2020-07-16 | 2022-01-20 | Hillary Hayman | Three-step process for mimicking plastic surgery results |
| CN114717230B (zh) * | 2021-01-05 | 2024-09-03 | 麦塞拿治疗(香港)有限公司 | 成纤维细胞生长因子mRNA的无细胞和无载体体外RNA转录方法和核酸分子 |
| WO2023012722A1 (en) * | 2021-08-06 | 2023-02-09 | Leadermed Champion Limited | miRNA-BASED COMPOSITIONS AND METHODS OF USE THEREOF |
| KR102432810B1 (ko) * | 2021-10-29 | 2022-08-16 | 주식회사 엣지케어 | 약물전달 시스템 및 약물전달 시스템의 동작방법 |
| US20240238473A1 (en) * | 2023-01-09 | 2024-07-18 | Beth Israel Deaconess Medical Center, Inc. | Recombinant nucleic acid molecules and their use in wound healing |
| CN120137909A (zh) * | 2025-03-12 | 2025-06-13 | 广州酷奇圈科研与推广应用有限公司 | 重组外泌体及其制备方法和应用 |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU773002B2 (en) | 1999-04-02 | 2004-05-13 | Kci Licensing, Inc. | Vacuum assisted closure system with provision for introduction of agent |
| US7202226B2 (en) * | 2000-10-23 | 2007-04-10 | Detroit R & D | Augmentation of wound healing by elF-4E mRNA and EGF mRNA |
| US20070299032A1 (en) * | 2003-11-11 | 2007-12-27 | Shiseido Company, Ltd. | Method and Composition for Thickening Hair |
| US7816140B2 (en) | 2005-06-14 | 2010-10-19 | The United States Of America As Represented By The Department Of Veterans Affairs | Composition and methods for osteogenic gene therapy |
| BRPI0619967A2 (pt) * | 2005-12-14 | 2011-10-25 | Organogenesis Inc | composições para o cuidado da pele |
| US20100143289A1 (en) | 2006-12-19 | 2010-06-10 | Michael Cohen | Umbilical cord stem cell secreted product derived topical compositions and methods of use thereof |
| WO2009030464A2 (de) | 2007-09-08 | 2009-03-12 | Bayer Schering Pharma Aktiengesellschaft | HERSTELLUNG UND VERWENDUNG VON VARIANTEN HUMANER KUNITZ-TYP PROTEASE-INHIBITOREN (hKTPI) |
| JP5553284B2 (ja) * | 2008-03-28 | 2014-07-16 | 株式会社ラボ・ジュヴェルサ | 皮膚の老化や瘢痕の治療剤 |
| WO2010037408A1 (en) | 2008-09-30 | 2010-04-08 | Curevac Gmbh | Composition comprising a complexed (m)rna and a naked mrna for providing or enhancing an immunostimulatory response in a mammal and uses thereof |
| DK2670411T3 (da) | 2011-02-02 | 2019-05-13 | Excaliard Pharmaceuticals Inc | Antisense-forbindelser rettet mod bindevævsvækstfaktor (CTGF) til anvendelse i en fremgangsmåde til behandling af keloider eller hypertrofiske ar |
| US8759287B2 (en) | 2011-04-12 | 2014-06-24 | M-3 Biologics, Llc | Methods of decreasing incisional hernia formation and acute wound failure in obese patients by administering basic fibroblast growth factor |
| WO2013002331A1 (ja) * | 2011-06-28 | 2013-01-03 | 株式会社バイオセレンタック | 皮膚治療用微細針集積型製剤 |
| US9439940B2 (en) | 2011-07-19 | 2016-09-13 | Neville Pharmaceutical, Inc. | Topical transdermal method for delivering nutrients through the skin for expeditied wound healing and skin rejuvenation |
| WO2013120497A1 (en) * | 2012-02-15 | 2013-08-22 | Curevac Gmbh | Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded therapeutic protein |
| US20150366997A1 (en) | 2012-12-07 | 2015-12-24 | Shire Human Genetics Therapies, Inc. | COMPOSITIONS AND METHODS FOR mRNA DELIVERY |
| KR102311614B1 (ko) | 2013-03-14 | 2021-10-08 | 샤이어 휴먼 지네틱 테라피즈 인크. | Cftr mrna 조성물 및 관련 방법 및 사용 |
| KR102415811B1 (ko) * | 2014-01-31 | 2022-07-04 | 팩터 바이오사이언스 인크. | 핵산 제조 및 송달을 위한 방법 및 산물 |
| WO2016100820A2 (en) | 2014-12-19 | 2016-06-23 | Salk Institute For Biological Studies | Fgf2 truncations and mutants and uses thereof |
| US11241505B2 (en) | 2015-02-13 | 2022-02-08 | Factor Bioscience Inc. | Nucleic acid products and methods of administration thereof |
| WO2017191274A2 (en) * | 2016-05-04 | 2017-11-09 | Curevac Ag | Rna encoding a therapeutic protein |
-
2017
- 2017-07-31 EP EP17183990.5A patent/EP3437650A1/en not_active Withdrawn
-
2018
- 2018-07-31 CN CN201880056980.3A patent/CN111050785A/zh active Pending
- 2018-07-31 AU AU2018311128A patent/AU2018311128A1/en not_active Abandoned
- 2018-07-31 CA CA3070880A patent/CA3070880A1/en active Pending
- 2018-07-31 US US16/635,857 patent/US20200369738A1/en not_active Abandoned
- 2018-07-31 KR KR1020207005199A patent/KR20200035073A/ko not_active Withdrawn
- 2018-07-31 WO PCT/EP2018/070712 patent/WO2019025431A1/en not_active Ceased
- 2018-07-31 EP EP18746712.1A patent/EP3661540A1/en active Pending
- 2018-07-31 JP JP2020505253A patent/JP2020529208A/ja active Pending
-
2023
- 2023-07-13 JP JP2023115343A patent/JP2023145532A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020515644A5 (cg-RX-API-DMAC7.html) | ||
| JP2023075165A (ja) | 核酸生成及び送達のための方法及び製品 | |
| US20170087224A1 (en) | Delivery methods and compositions | |
| CN109381422B (zh) | 一种经皮吸收组合物及其在制备经皮吸收制剂中的用途 | |
| JP2018506542A5 (cg-RX-API-DMAC7.html) | ||
| EP3275459A2 (en) | Method for promoting hair growth and preventing hair loss of patient, composition therefor, and method for preparing composition | |
| Xing et al. | Microenvironment-responsive recombinant collagen XVII-based composite microneedles for the treatment of androgenetic alopecia | |
| KR102760486B1 (ko) | 다중-인자 모발 성장 제제 | |
| Bhat et al. | Can breakthroughs in dermal and transdermal macromolecule delivery surmount existing barriers and revolutionize future therapeutics? | |
| JP2020529208A (ja) | 局所皮膚低栄養状態の治療 | |
| KR20190123256A (ko) | 액취증 치료 방법 | |
| Bhavsar et al. | Strategies for transportation of peptides across the skin for treatment of multiple diseases | |
| CN117050164A (zh) | 透皮增强肽及其应用 | |
| CN112245571A (zh) | 一种用于乌发的脂质体制剂及其制备方法 | |
| CN106084006B (zh) | 一种透皮肽及其应用 | |
| Abdul Aziz et al. | A review on the mechanisms, applications, and clinical trials of advanced technologies in the transdermal drug delivery system | |
| CN121421927A (zh) | 一种高活性外泌体生发促进剂的制备方法 | |
| WO2005039642B1 (en) | Dna delivery with gemini cationic surfactants | |
| RU2012146542A (ru) | Способ ингибирования репликации вич в клетках млекопитающих и у людей | |
| Zhang et al. | mRNA-based therapeutics in skin regeneration and rejuvenation: From optimization strategies to translational advances | |
| CN113316459A (zh) | 包含皮肤穿透核酸复合物作为有效成分的用于预防或治疗特应性皮炎的组合物 | |
| EP1671655A1 (en) | Gene therapy for skin diseases using needle free syringe | |
| Chen et al. | Research progress on the application of microneedle transdermal drug delivery system in dermatology | |
| EP3490572A1 (en) | Skin care formulation | |
| Li et al. | Elastin-like peptides for efficient and safe delivery of mRNA |